The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

por Akyildiz, Arif, Guven, Deniz Can, Ozluk, Ahmet Anil, Ismayilov, Rashad, Mutlu, Emel, Unal, Olcun Umit, Yildiz, Ibrahim, Iriagac, Yakup, Turhal, Serdar, Akbas, Sinem, Bayram, Ertugrul, Telli, Tugba Akin, Turkoz, Fatma Paksoy, Ozcelik, Melike, Erciyestepe, Mert, Selvi, Oguzhan, Gulbagci, Burcu, Erturk, Ismail, Isleyen, Zehra Sucuoglu, Kahraman, Seda, Akdag, Mutianur Ozkorkmaz, Hamitoglu, Buket, Unek, Ilkay Tugba, Unal, Caglar, Hacibekiroglu, İlhan, Arslan, Cagatay, Azizy, Abdulmunir, Helvaci, Kaan, Demirci, Umut, Dizdar, Omer, Basaran, Mert, Goker, Erdem, Sendur, Mehmet Ali, Yalcin, Suayib
Publicado 2023